ADIL.O (ADIL.O) News
Follow ADIL.O (ADIL.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Adial Pharmaceuticals Delays Shareholder Meeting to Oct. 26 Pending Nasdaq Approval
Adial Pharmaceuticals further adjourned its 2026 annual shareholder meeting to October 26 at 8:30 a.m. Eastern Time, pending Nasdaq listing approval. Voting remains open on four proposals postponed again on October 15; t
REGULATION | Oct 16, 2026, 09:18 PM UTC
L
Adial Pharmaceuticals Appoints David Rubenstein as Chief Scientist
Adial Pharmaceuticals appointed David Rubenstein as chief scientist to lead its research and scientific strategy. Rubenstein previously served as Dermavant Sciences’ chief scientific officer, leading tapinarof developmen
NEWS | Oct 16, 2026, 11:03 AM UTC